163 related articles for article (PubMed ID: 29480994)
1. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis.
Aboushousha T; Hammam O; Helal N; El Dahshan S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):513-519. PubMed ID: 29480994
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
3. Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
Nahar R; Jinnah MSA; Karim SS; Alam MM; Khatun J; Kabir E; Aktar M
Mymensingh Med J; 2024 Apr; 33(2):461-465. PubMed ID: 38557526
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
8. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
Fristrup N; Birkenkamp-Demtröder K; Reinert T; Sanchez-Carbayo M; Segersten U; Malmström PU; Palou J; Alvarez-Múgica M; Pan CC; Ulhøi BP; Borre M; Ørntoft TF; Dyrskjøt L
Am J Pathol; 2013 Feb; 182(2):339-49. PubMed ID: 23201130
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
11. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas.
Karakaya YA; Oral E
Indian J Pathol Microbiol; 2021; 64(1):84-90. PubMed ID: 33433414
[TBL] [Abstract][Full Text] [Related]
14. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
Levidou G; Gakiopoulou H; Kavantzas N; Saetta AA; Karlou M; Pavlopoulos P; Thymara I; Diamantopoulou K; Patsouris E; Korkolopoulou P
BJU Int; 2011 Jul; 108(2 Pt 2):E59-65. PubMed ID: 21062395
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
Yang CC; Chu KC; Chen HY; Chen WC
Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
[TBL] [Abstract][Full Text] [Related]
18. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
[TBL] [Abstract][Full Text] [Related]
19. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
Tominaga M; Sueoka N; Irie K; Iwanaga K; Tokunaga O; Hayashi S; Nakachi K; Sueoka E
Lung Cancer; 2003 Apr; 40(1):45-53. PubMed ID: 12660006
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclin d1 and its association with disease characteristics in bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Dec; 33(12):5235-42. PubMed ID: 24324055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]